Nick talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Click here to download audio, watch video, or read show notes & transcripts.
If you enjoy my content and want to further support M&M, please read this.
Demetrix & Bioengineering Rare Cannabinoids | Jeff Ubersax | #14 | Supported by Demetrix